Taisho Pharmaceutical Co., Ltd. [Head Office: Toshima-ku, Tokyo; President: Shigeru Uehara] (hereinafter referred to as "the Company") will launch "Pabron Allergic Rhinitis Fexofenadine Tablets" (Class 2 Specified-Class 2 OTC Drugs) on Wednesday, July 1, 2026.

"Pabron Allergic Rhinitis Fexofenadine Tablets" is an allergy-specific rhinitis medication containing the active ingredient fexofenadine hydrochloride. By suppressing the action of histamine, which causes allergic symptoms, it improves bothersome symptoms such as runny nose and nasal congestion due to hay fever. Furthermore, fexofenadine hydrochloride is known as an ingredient that causes less drowsiness, and the formulation is designed to minimize impact on daytime activities such as work, study, and housework.

Through "Pabron Allergic Rhinitis Fexofenadine Tablets," the Company will support the comfortable daily lives of consumers suffering from allergic symptoms.

◇ Product Features

* Effective and non-drowsy

* Contains "fexofenadine hydrochloride," a second-generation histamine ingredient

* Does not significantly reduce concentration

* Does not cause dry mouth

* Effective for 24 hours with twice-daily dosing

◇ Product Overview

Product Name: Pabron Allergic Rhinitis Fexofenadine Tablets

Product Classification: Class 2 Specified-Class 2 OTC Drugs

Details: 28 tablets, 56 tablets, 84 tablets

Suggested Retail Price

(Tax Included) 28 tablets: \2,068

56 tablets: \3,828

84 tablets: \5,478

Efficacy and Effects: Relief of the following nasal allergy symptoms caused by pollen, house dust (indoor dust), etc.: sneezing, runny nose, nasal congestion

Dosage and Administration: Adults (15 years and older) take 1 tablet once, twice daily (morning and evening), with water or lukewarm water. Do not administer to children under 15 years of age.

Ingredients: Fexofenadine hydrochloride 120mg (per daily dose: in 2 tablets)

Additives: Cellulose, partially pregelatinized starch, povidone, crospovidone, anhydrous silicic acid, magnesium stearate, hypromellose, talc, titanium dioxide, macrogol, yellow iron oxide, red iron oxide

Launch Date: Wednesday, July 1, 2026

◇ Product Catalog

URL: https://www.catalog-taisho.com/category/02/003/04269/

◇ Inquiries about the product from consumers

Customer Service Center TEL: 0120-721-800

FACT BOX

  • Source: PR TIMES
  • Category: 製品発売